Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Primary Inoperable Thymoma × Octreotide × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thymoma 2 Primary Inoperable Thymoma 1 Pleural Effusion 1 Neoplasms 1 Lymphangiomyoma 1 Lymphangioleiomyomatosis 1 Disease 1 Chylous Ascites 1 Chylothorax 1 Ascites 1

Interventions

pasireotide 1 Octreotide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02021942 2018-02-05

Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size

University of Regensburg

Phase 2 Completed

16 enrolled 11 charts

Primary Inoperable Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡